Success Stories: An Indian Adjunct Research Associate Secured EB-1A Approval with the Help of Our Personalized Petition packet
Client’s Testimonial:
“Very prompt and to the point answers to your questions. they explain everything to you. Great work.”
On February 10th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for an Adjunct Research Associate in the Field of Nanotechnology (Approval Notice).
General Field: Nanotechnology
Position at the Time of Case Filing: Adjunct Research Associate
Country of Origin: India
State of Residence at the Time of Filing: Florida
Approval Notice Date: February 10th, 2021
Processing Time: 9 days (Premium Processing Requested)
Case Summary:
When an Indian adjunct research associate based in Florida contacted us to prepare an EB-1A (Alien of Extraordinary Ability) petition on her behalf, firstly, we evaluated her academic background as she held a Ph.D. in chemistry and is a highly qualified advanced degree scientist with vast knowledge and experience in photomedicine, cancer biology, and entomology prove her to be an invaluable resource to the United States. We were highly impressed with her publication and citation record, and her overall record of success and notable influence in the field of nanotechnology. On the basis of our client’s research accomplishments, we decided to take her case and countersign the client-attorney contract. We composed all the necessary documents to be submitted to the USCIS and assembled a well-structured petition.
“Not only is [client’s] work extraordinary on its own scientific merits, but it promises better results and better quality of life for the millions of people suffering from cancer in the United States.” This excerpt is taken from one of the four recommendation letters provided by our client obtained from her fellow experts in the field, thereby contributing more insights to the inherent value of her research in the field of nanotechnology.
We further demonstrated her research focusing on the development of a multimodal multifunctional quantum dot drug delivery system, addressing some of our nation’s most pressing issues, including developing novel therapies for debilitating diseases such as cancer and for addressing problems related to the epidemic outbreaks of vector-borne diseases.
We also recorded the 12 peer-reviewed scientific articles she published in some of the most eminent journals in the field. Her publications have been cited by researchers in at least 38 countries, confirming that these publications are widely recognized in the field.
We detailed our client’s peer-review participation as well, at the time of filing, she had already conducted 14 reviews for highly acclaimed journals.
In addition, we noted the 180 citations her work gathered from independent and leading researchers from reputable institutions, signifying the major influence of her work on other well-knowledgeable researchers.
Considering all the aforementioned details, we submitted our client’s EB-1A petition to USCIS, and with the great help of our team’s support as well as premium processing service, she received her petition approval in just 9 days. We indeed are glad at our client’s achievement and thank her for choosing our law firm.